Metraipolis › archive › dc_fae036abc06e

RTN4IP1 mutation and endocrine failure: clinical features and possible benefits of coenzyme Q10 — Europe PMC PMID:41609474

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41609474
DOI: 10.1530/ec-25-0768
License (as archived): solo-consultazione
Archived: 2026-11-05T20:23:46.067Z
SHA-256 of the archived text: e51fbe1b7fe4183808af94eb1fdc75993461e9648e79f847320b183532ee6f3a
Stable URL of this page: https://metraipolis.com/documento/dc_fae036abc06e

How to cite

RTN4IP1 mutation and endocrine failure: clinical features and possible benefits of coenzyme Q10 — Europe PMC PMID:41609474 — Europe PMC (en), https://europepmc.org/article/MED/41609474 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fae036abc06e (Metraipolis archive dc_fae036abc06e, sha256 e51fbe1b7fe4183808af94eb1fdc75993461e9648e79f847320b183532ee6f3a)

BibTeX

@misc{dcfae036abc06e,
  title = {RTN4IP1 mutation and endocrine failure: clinical features and possible benefits of coenzyme Q10 — Europe PMC PMID:41609474},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41609474},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fae036abc06e; sha256 e51fbe1b7fe4183808af94eb1fdc75993461e9648e79f847320b183532ee6f3a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41609474. Agents can read the archived copy with the MCP tool read_document.